Y Intercept (Hong Kong) LTD Charles River Laboratories International, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.37 Billion
- Q1 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 3,760 shares of CRL stock, worth $449,094. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,760Holding current value
$449,094% of portfolio
0.04%Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
692Shares Held
50.3MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$736 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$608 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$261 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$216 Million0.79% of portfolio
-
Allspring Global Investments Holdings, LLC1.77MShares$212 Million0.5% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.08B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...